IQV - Healthcare Analytics Solutions Provider IQVIA Cuts Annual Forecast Sees Demand Slowing For Services | Benzinga
IQVIA Holdings Inc (NYSE: IQV) reported Q3 sales of $3.74 billion, up 4.9% Y/Y on a reported basis and 4.1% at constant currency (CC), missing the consensus of $3.78 billion.
IQVIA reported Q3 adjusted EPS of $2.49, beating the consensus of $2.44.
Technology & Analytics Solutions revenue increased 2.2% (0.9% CC) to $1.43 billion.
Research & Development Solutions (R&DS) sales reached $2.12 billion, +7.2% (6.4% CC).
Contract ...